Partnering/Investor Relations

Dentamach acquired its first dental laboratory, in October 2008 and our planned objective is to acquire dental labs that generate  an aggregate annual sales of $25 million by December 2010. Our business model is such that our acquisitions are generally profitable in the month after the acquisition. The dental laboratory industry is a highly fragmented industry and it is oversaturated. There are 15,000 dental labs in North America and therefore the industry is in need of consolidation if the individual labs are to remain profitable. Please review our appended Brochure directed at lab owners for more details.

Dentamach is already in the top 1 percentile after implementing different sales and marketing strategies, during the first 2 years of the program. Our operating subsidiaries currently generate a positive cash flow and at this stage of the company we are looking for the kind of regional executives and/or strategic partners that will help catapult the company into becoming the top dental manufacturing company worldwide.

When we open a region in the USA, there is substantial up front costs but those cost have now been dramatically reduced because we already have a corporate infrastructure. The first region we opened cost about $1 million in start up funds but with our current knowledge we can successfully start up a region for about $400K.

Currently we are looking for Regional Presidents and/or Vice Presidents of Mergers and Acquisition to become equity partners. Our equity partners are not only be responsible for acquiring dental laboratories in their region of choice but will also be responsible for managing the P&L and Marketing of the regional dental laboratories that they acquire. We are looking for equity partners (swat equity and/or investors) located in major metropolitan such as. Atlanta, Chicago, Dallas, Texas LA etc)

We are also for looking for technology partners who wish to license to Dentamach a dental product and/or medical device that they have developed and patented. If you are interested in becoming a strategic or joint venture operating partner please contact: Carmella Angus at 973-658-4783

Click here for our corporate brochure

Disclaimer: Certain statements in this Website may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements that address expectations or projections about the future, including statements about product development, market position, expected expenditures and financial results, are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. These statements are not guarantees of future performance and involve some risks, uncertainties and assumptions. Accordingly, actual results or performance of Dentamach International may differ significantly from the forward-looking statements made herein. Unanticipated events and circumstances are likely to occur. Factors that might cause such differences include, but are not limited to those discussed under the heading "Risk Factors," which investors should carefully consider. These factors include, but are not limited to, risks that the Company's products and services may not achieve the anticipated market acceptance; the Company may not be able to secure anticipated funding; intense competition in the industry may result in lower-than-anticipated revenues and cash flow, or higher- than-anticipated costs; and general economic conditions, such as the employment rate, inflation, interest rates and the condition of the capital markets may change in ways that are not favorable to the Company. This list of factors is not exclusive. The Company is not obligated to update any forward-looking statements.